These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2850431)

  • 1. Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents.
    Majumdar S; Zoghbi SS; Gore JC
    Magn Reson Imaging; 1988; 6(6):611-5. PubMed ID: 2850431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a superparamagnetic iron oxide (AMI-25) as a brain contrast agent.
    Kent TA; Quast MJ; Kaplan BJ; Lifsey RS; Eisenberg HM
    Magn Reson Med; 1990 Mar; 13(3):434-43. PubMed ID: 2325543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note.
    Jin S; Kang M; Cho H
    PLoS One; 2018; 13(7):e0201076. PubMed ID: 30044884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media.
    van Bruggen N; Busch E; Palmer JT; Williams SP; de Crespigny AJ
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1178-83. PubMed ID: 9809506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging.
    Gore JC; Majumdar S
    Magn Reson Med; 1990 May; 14(2):242-8. PubMed ID: 2189053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR contrast due to intravascular magnetic susceptibility perturbations.
    Boxerman JL; Hamberg LM; Rosen BR; Weisskoff RM
    Magn Reson Med; 1995 Oct; 34(4):555-66. PubMed ID: 8524024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q.
    Wu EX; Tang H; Jensen JH
    NMR Biomed; 2004 Nov; 17(7):507-12. PubMed ID: 15523704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents.
    Majumdar S; Zoghbi SS; Gore JC
    Magn Reson Med; 1989 Jun; 10(3):289-301. PubMed ID: 2733587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early behaviour of 99mTc-pertechnetate in the head after intravenous bolus injection: its relevance to the cerebral blood circulation.
    Keyeux A; Ochrymowicz-Bemelmans D
    Eur J Nucl Med; 1983; 8(5):196-200. PubMed ID: 6307699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection with echo-planar MR imaging of transit of susceptibility contrast medium in a rat model of regional brain ischemia.
    Wendland MF; White DL; Aicher KP; Tzika AA; Moseley ME
    J Magn Reson Imaging; 1991; 1(3):285-92. PubMed ID: 1802141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle cerebral artery occlusion in rats studied by magnetic resonance imaging.
    Bradley RH; Kent TA; Eisenberg HM; Quast MJ; Ward GA; Campbell GA; Hillman G
    Stroke; 1989 Aug; 20(8):1032-6. PubMed ID: 2667200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusion.
    Rozneman Y; Zou XM; Kantor HL
    Magn Reson Med; 1990 Apr; 14(1):31-9. PubMed ID: 2352471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological properties of complex iron oxide nanoparticles entering in magnetic resonance tomography contrast agent].
    Akopdzhanov AG; Sergeev AI; Manvelov EV; Semeĭkin AV; Naumenko VIu; Panov VO; Bykov IV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2010 Jun; 73(6):23-8. PubMed ID: 20726347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles.
    Yeh TC; Zhang W; Ildstad ST; Ho C
    Magn Reson Med; 1995 Feb; 33(2):200-8. PubMed ID: 7707910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative vascular neuroimaging of the rat brain using superparamagnetic nanoparticles: New insights on vascular organization and brain function.
    Gharagouzloo CA; Timms L; Qiao J; Fang Z; Nneji J; Pandya A; Kulkarni P; van de Ven AL; Ferris C; Sridhar S
    Neuroimage; 2017 Dec; 163():24-33. PubMed ID: 28889004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles.
    Gharehaghaji N; Oghabian MA; Sarkar S; Amirmohseni S; Ghanaati H
    J Nanosci Nanotechnol; 2009 Jul; 9(7):4448-52. PubMed ID: 19916472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T.
    Lu H; Scholl CA; Zuo Y; Stein EA; Yang Y
    Magn Reson Med; 2007 Sep; 58(3):616-21. PubMed ID: 17763339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.